Talecris to announce expansion, shares company results

Talecris Biotherapeutics on Friday is expected to announce a plan to expand its plant in North Carolina. The first phase of the expansion is anticipated to be a $280 million facility for the separation of blood plasma proteins used in drug development. The company also reported an increase in revenue and profit during the third quarter, owing to sales of its blood plasma-derived drug products.

View Full Article in:

News & Observer (Raleigh, N.C.), The · News & Observer (Raleigh, N.C.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
The Pew Charitable Trusts
Director, Antibiotics and Innovation Project
Washington, DC
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC